May 22, 2026 - ChartAlert®

HINDALCO – Hindalco Industries – Q4 FY26 Financial Results – 22-May-26

Hindalco’s FY26 delivered ~10% pre‑exceptional earnings growth on 15% revenue jump, but debt rose ~56%, inventory ballooned 55%, and FCF turned negative amid capex bets. Novelis EBITDA/tonne recovery is the swing factor; FY26 is a transition year — watch Novelis margins, inventory normalization, and OCF recovery for re‑rating.

1–2 minutes

🔍 Observations

Topline

Consolidated revenue surged 15.3% YoY (₹2,38,496 Cr → ₹2,74,944 Cr), with Q4FY26 alone jumping 20.4% YoY (₹64,890 Cr → ₹78,133 Cr) — broadest quarterly run-rate in recent history.
Copper segment drove outsized topline contribution, growing 27.7% YoY (₹54,703 Cr → ₹69,838 Cr); Aluminium downstream accelerated 24.3% YoY (₹12,819 Cr → ₹15,938 Cr).
Novelis, the largest segment at 59% of revenue, grew a modest 12.3% YoY (₹1,45,068 Cr → ₹1,62,882 Cr) — volume/mix, not commodity tailwinds, likely driving it.

Bottomline

Reported PAT declined 16.3% YoY (₹16,002 Cr → ₹13,391 Cr), distorted entirely by exceptional charges of ₹6,963 Cr in FY26 vs. ₹879 Cr in FY25.
Pre-exceptional PBT grew 9.7% YoY (₹23,216 Cr → ₹25,459 Cr), confirming underlying earnings power is intact and expanding.
EPS (basic) compressed to ₹60.31 from ₹72.05 — optically weak, but exceptional-item-driven; core trajectory is positive.

Margins

Segment EBITDA expanded to ₹37,217 Cr from ₹35,162 Cr (+5.8% YoY); consolidated EBITDA (segment results + unallocable, pre-finance/D&A) at ₹38,097 Cr vs. ₹35,496 Cr (+7.3% YoY).
EBITDA margin on revenue from operations: 38,097 / 2,74,944 = 13.9% vs. 35,496 / 2,38,496 = 14.9% — 100 bps compression YoY, partly attributable to Copper’s lower-margin revenue mix growing fastest.
Aluminium upstream segment result improved to ₹18,884 Cr from ₹16,262 Cr (+16.1% YoY) — the highest-margin segment delivering the best absolute growth.

Growth Trajectory

Revenue CAGR implied over two years is healthy, but working capital consumption is accelerating disproportionately — a structural flag for FY27 free cash flow visibility.
Aluminium downstream, though small, grew 54.5% in segment results (₹633 Cr → ₹978 Cr) — early signs of downstream value-add monetisation.
Novelis segment result fell 4.6% YoY (₹15,242 Cr → ₹14,546 Cr) despite revenue growth — margin dilution at the most important subsidiary warrants monitoring.

EICHERMOT – Eicher Motors – Q4 FY26 Financial Results – 22-May-26

Eicher Motors’ FY26 delivered 24% revenue growth, ₹3,530 Cr FCF, near‑zero leverage, and VECV JV momentum. Risks: 150 bps PAT margin compression and Q4 revenue stall. Re‑rating now hinges on margin leverage from new platforms and global scale‑up; treasury earnings floor strong but RE must grow without dilution.

1–2 minutes

🔍 Observations

Topline

Revenue from operations crossed ₹23,408 Cr in FY26 vs ₹18,870 Cr in FY25 — 24.0% YoY growth, driven by Royal Enfield volume expansion and premiumisation
Q4FY26 revenue at ₹6,080 Cr vs ₹5,241 Cr in Q4FY25 — 16.0% YoY growth; sequentially flat vs Q3FY26 (₹6,114 Cr)
Other income (investment returns) rose to ₹1,487 Cr in FY26 from ₹1,305 Cr — meaningful contributor given the large treasury corpus

Bottomline

PAT grew 16.5% YoY to ₹5,515 Cr (FY26) from ₹4,734 Cr (FY25); Q4FY26 PAT at ₹1,520 Cr, up 11.6% vs Q4FY25 (₹1,362 Cr)
JV profit contribution (VECV) rose to ₹798 Cr in FY26 from ₹700 Cr — 14.0% YoY; Q4FY26 VECV share surged to ₹323 Cr vs ₹248 Cr in Q4FY25
Basic EPS expanded to ₹201.09 in FY26 from ₹172.76 in FY25 — 16.4% YoY growth

Margins

FY26 EBITDA (PBT before JV + D&A + Finance costs): ₹6,359.70 + ₹840.37 + ₹71.53 = ₹7,271.60 Cr on revenue of ₹23,408 Cr → EBITDA margin ~31.1% vs ~30.7% in FY25 (₹5,233.26 + ₹729.33 + ₹54.34 = ₹6,016.93 Cr / ₹18,870 Cr) — marginal expansion
Net profit margin (PAT / Revenue from ops): 5,515 / 23,408 = 23.6% vs 4,734 / 18,870 = 25.1% in FY25 — 150bps compression, partly from higher tax (effective rate rose from 20.2% to 22.3%)
Raw material + traded goods as % of revenue: (12,502 + 835 − 270) / 23,408 = 55.4% vs (9,953 + 507 − 164) / 18,870 = 54.8% — modest input cost inflation absorbed

Growth Trajectory

Revenue CAGR at 24% for FY26 points to strong demand; sequential flatness in Q4 warrants watching for volume plateau
PAT growth (16.5%) lagging revenue growth (24.0%) signals operating leverage not fully flowing through — cost base scaling faster than topline
VECV’s improving profit trajectory (14% YoY) adds earnings resilience via non-motorcycle diversification

SUNPHARMA – Sun Pharmaceutical Industries – Q4 FY26 Financial Results – 22-May-26

Sun Pharma’s FY26 delivered 11% topline growth with ~31.5% EBITDA margins, specialty pivot sustaining quality. PAT up 5% understates strength; underlying trajectory solid. Re‑rating hinges on specialty‑led margin inflection toward 34–35%. Risks: faster opex growth, acquisition integration, intangibles spike, and receivables build.

1–2 minutes

🔍 Observations

Topline

Revenue from operations grew 11.2% YoY (₹525,784 Mn → ₹584,620 Mn), driven by both domestic formulations and specialty/global generic expansion.
Q4FY26 revenue of ₹146,118 Mn grew 12.8% YoY vs Q4FY25 (₹129,588 Mn), though declined 5.9% QoQ from Q3FY26’s ₹155,205 Mn — seasonal softness, not structural.
Other operating revenues fell sharply (₹5,372 Mn → ₹2,419 Mn YoY), a ₹2,953 Mn headwind to topline largely absorbed by core revenue momentum.

Bottomline

Reported PAT grew 5.0% YoY (₹109,290 Mn → ₹114,794 Mn); adjusted for ₹13,075 Mn of exceptional items in FY26 vs ₹6,779 Mn in FY25, underlying PAT growth is broadly similar.
Tax outflow surged — effective tax rate on reported PBT rose from ~17.4% to ~26.0% — compressing PAT despite strong EBIT growth; a large one-off deferred tax reversal benefited FY25.
EPS grew modestly from ₹45.6 to ₹47.8 (basic), with no dilution — share count flat at ~2,399 Mn shares.

Margins

EBITDA (PBT before exceptional + Finance costs + D&A): FY26 = ₹151,189 + ₹3,389 + ₹29,379 = ₹183,957 Mn on revenue of ₹584,620 Mn → EBITDA margin ~31.5% vs FY25: ₹137,521 + ₹2,314 + ₹25,754 = ₹165,589 Mn on ₹525,784 Mn → 31.5%. Margins held flat despite R&D intensity rising.
Net profit margin: ₹114,794 / ₹584,620 = 19.6% vs ₹109,290 / ₹525,784 = 20.8% — 120 bps compression, driven entirely by tax normalisation.
R&D spend rose to ₹34,741 Mn (5.9% of revenue) vs ₹31,542 Mn (6.0%) — pipeline investment sustained without margin sacrifice.

Growth Trajectory

Three-year revenue compound implied by 11.2% topline growth and consistent specialty mix shift signals durable mid-teens USD revenue CAGR in global markets.
Employee costs grew 14.5% YoY (₹99,731 Mn → ₹114,189 Mn), outpacing revenue — talent investment for specialty scaling, but warrants monitoring.
Other expenses grew 13.3% YoY (₹167,718 Mn → ₹190,083 Mn) — faster than revenue, suggesting operating leverage yet to fully materialise.

TORNTPHARMA – Torrent Pharmaceuticals – Q4 FY26 Financial Results – 22-May-26

Torrent Pharma’s FY26 vaulted revenues past ₹13,900 Cr via acquisition, but net debt/EBITDA ~2.9x and ₹24,280 Cr intangibles suppress PAT. Core remains resilient with ₹2,346 Cr FCF and ~31% EBITDA margins. Re‑rating hinges on brand revenue scaling faster than amortisation; watch receivables and finance costs.

1–2 minutes

🔍 Observations

Topline

Revenue from ops grew 21.4% YoY (₹11,516 Cr → ₹13,980 Cr), reflecting the step-up from an acquired business consolidating into FY26 numbers.
Q4FY26 printed ₹4,197 Cr — +41.8% YoY and +27.1% QoQ — the sharpest quarterly outturn, indicating the full consolidation effect landed in Q4.
Other income turned negative in FY26 (–₹94 Cr vs +₹23 Cr), reflecting forex and hedging losses that clipped reported total income.

Bottomline

Net profit grew 11.9% YoY (₹1,911 Cr → ₹2,138 Cr), well below revenue growth — margin dilution from acquisition-linked D&A and finance costs.
Q4FY26 net profit collapsed to ₹364 Cr vs ₹498 Cr in Q4FY25 (–26.9% YoY), driven by ₹236 Cr finance costs, ₹508 Cr D&A, and ₹66 Cr exceptional charges in a single quarter.
Effective tax rate improved to 25.6% (from 28.5%), providing partial offset; without this, PAT growth would have been thinner still.

Margins

EBITDA margin contracted ~100 bps to 31.3% (FY26) from 32.3% (FY25) — operating leverage partly absorbed by employee cost growth of 21.2% YoY.
Net profit margin compressed 130 bps to 15.3%, squeezed by D&A surging 40.8% and finance costs up 52.8%.
Q4FY26 EBITDA margin held at 31.9% (vs 32.0% in Q4FY25) — the operational core is stable; below-EBITDA lines are where the dilution originates.

Growth Trajectory

Organic revenue growth is likely sub-15%; the headline 21.4% is acquisition-inflated — normalisation will depend on how fast the acquired portfolio integrates.
EPS grew 13.2% (₹56.47 → ₹63.92) despite no equity dilution — share count unchanged at 169.23 Cr shares — all growth is earnings-driven on the legacy base.
D&A will remain elevated for multiple years as ₹24,280 Cr of intangible assets amortise; this is the single biggest structural drag on reported PAT growth.

PRESTIGE – Prestige Estates Projects – Q4 FY26 Financial Results – 21-May-26

1–2 minutes

🔍 Observations

Topline

Revenue surged 72.6% YoY (₹73,494 Mn → ₹126,854 Mn), with Q4FY26 alone delivering 166.5% YoY growth (₹15,284 Mn → ₹40,738 Mn) — the strongest quarter on record.
Sequential momentum held: Q4FY26 revenue grew 5.2% over Q3FY26 (₹38,726 Mn), signaling consistent delivery throughput rather than a one-quarter flush.
Revenue scale now reflects accelerated project completions and handovers, typical of Prestige’s POC-revenue recognition model.

Bottomline

PAT more than doubled YoY (₹6,169 Mn → ₹13,054 Mn, +111.6%), with Q4FY26 PAT of ₹2,918 Mn against ₹431 Mn in Q4FY25 — a 577% YoY jump driven by operating leverage and deferred tax reversals.
EPS expanded 148% YoY (₹11.19 → ₹27.76), compounding the effect of the FY25 QIP dilution now being earnings-accretive.
Tax efficiency aided FY26 PAT: effective tax rate was 23.8% (₹4,082 Mn on ₹17,136 Mn PBT), supported by ₹4,818 Mn deferred tax credit.

Margins

EBITDA margin compressed 640 bps YoY (39.5% → 33.1%) despite absolute EBITDA growing 44.8% (₹29,019 Mn → ₹42,021 Mn) — scale comes at a margin cost as lower-margin projects are completed.
Q4FY26 EBITDA margin contracted sharply to 26.5% vs 38.6% in Q4FY25, pointing to higher land costs (₹14,808 Mn in Q4 alone) and contractor cost dilution in the quarter’s mix.
Net margin improved 190 bps (8.4% → 10.3%), as finance cost leverage and deferred tax benefits more than offset operating margin dilution.

Growth Trajectory

Revenue CAGR implied over FY25–26 is 72.6% — unsustainably rapid, but reflects a genuine step-change in delivery scale, not accounting optionality.
Inventory on the balance sheet grew 26.3% (₹318,831 Mn → ₹402,519 Mn) alongside customer advances growing 31.3% (₹250,732 Mn → ₹329,438 Mn) — pipeline is robust and pre-sold.
Finance costs grew 18.6% YoY (₹13,338 Mn → ₹15,824 Mn), slower than revenue growth — a structural positive as leverage cost is being absorbed into expanding revenue.

ADSL – Allied Digital Services – Q4 FY26 Financial Results – 21-May-26

Allied Digital’s FY26 delivered 22.3% revenue growth with 33% EBIT margins, but unallocated costs (~80% of EBIT), ₹17,381L opaque loan outflow, and Q4 cost‑driven loss cloud visibility. Reported 10.2% PAT growth is tax‑driven; with PBT down 28.3%, disclosure clarity is essential before re‑rating.

1–2 minutes

🔍 Observations

Topline

Revenue from operations grew 19.9% YoY (₹80,707L → ₹96,791L), driven predominantly by the Services segment (₹61,800L → ₹75,614L, +22.3% YoY).
Q4FY26 revenue hit ₹26,777L, up 31.0% YoY vs Q4FY25’s ₹20,435L — strongest quarterly print of the year.
Solutions segment contributed ₹21,177L in FY26 vs ₹18,907L in FY25 (+12.0% YoY), growing but at a slower pace than Services.

Bottomline

PAT rose 10.2% YoY (₹3,226L → ₹3,553L) on a consolidated basis, but Q4FY26 turned loss-making at ₹(339)L vs ₹(746)L loss in Q4FY25 — a sequential reversal after a profitable Q3FY26 (₹1,391L).
PBT fell 28.3% YoY (₹6,077L → ₹4,358L) despite higher revenue, signaling significant cost escalation outpacing topline growth.
Deferred tax credit of ₹2,117L in FY26 (vs ₹549L charge in FY25) materially supported reported PAT; underlying operational profitability deteriorated.

Margins

Segment EBIT (Services + Solutions combined) expanded to ₹28,112L vs ₹23,215L (+21.1% YoY), but unallocated expenses surged to ₹22,444L from ₹16,440L (+36.5% YoY), eroding PBT entirely.
Net profit margin compressed to 3.7% in FY26 vs 4.0% in FY25 (PAT/Revenue from operations).
Q4FY26 shows total expenses of ₹28,641L against revenue of ₹26,777L — a negative operating quarter, driven by a spike in purchases & other direct expenses (₹17,229L vs ₹8,278L in Q4FY25) and other expenses (₹5,935L vs ₹7,551L).

Growth Trajectory

Three-year revenue trajectory is directionally positive, but PBT declining 28.3% YoY on 19.9% revenue growth signals a profitability ceiling forming at current cost structures.
Unallocated expenses growing at 36.5% vs revenue at 19.9% is unsustainable; if this gap persists, FY27 PBT will likely compress further.
Services segment EBIT margin: ₹24,942L on ₹75,614L revenue = 33.0% in FY26 vs ₹20,386L on ₹61,800L = 33.0% in FY25 — flat, indicating no operating leverage despite scale.

GAIL – GAIL India Ltd – Q4 FY26 Financial Results – 21-May-26

GAIL’s FY26 shows regulated transmission/city gas resilience but commodity fragility — gas marketing spread compression and petrochemical losses erased ₹6,000 Cr EBIT. Capex builds pipeline/tariff upside, but near‑term hinges on spread normalization and petrochem breakeven. Dividend risk: FY26 payouts exceeded FCF via borrowing, unsustainable without FY27 earnings recovery.

1–2 minutes

🔍 Observations

Topline

Revenue from operations flat YoY at ₹1,42,094 Cr vs ₹1,42,290 Cr (-0.1%) — Natural Gas Marketing dominance (~₹1,44,713 Cr gross) masks transmission and city gas growth beneath a stagnant headline.
Q4FY26 revenue at ₹35,705 Cr declined 2.3% YoY vs Q4FY25’s ₹36,549 Cr, with Natural Gas Marketing segment bearing most of the pressure.
City Gas segment bucked the trend — full-year revenue grew 22.3% YoY (₹6,052 Cr → ₹7,401 Cr), the strongest growth vector across all segments.

Bottomline

Net profit collapsed 39.2% YoY (₹12,463 Cr → ₹7,582 Cr); FY25 included ₹2,440 Cr exceptional income, but even on comparable pre-exceptional basis PBT fell 39.6% (₹13,655 Cr → ₹9,725 Cr).
Q4FY26 PAT at ₹1,481 Cr fell 40.9% vs Q4FY25’s ₹2,506 Cr — deterioration accelerated in Q4, not just a full-year averaging effect.
Petrochemicals swung to a deep loss of ₹1,410 Cr EBIT in FY26 vs near-breakeven ₹(41) Cr in FY25; Natural Gas Marketing EBIT crashed 59.3% (₹7,795 Cr → ₹3,175 Cr).

Margins

EBITDA proxy (PBT + Finance Cost + Depreciation, before JV share): ₹9,725 + ₹964 + ₹3,835 = ₹14,524 Cr on revenue of ₹1,42,094 Cr → EBITDA margin ~10.2% vs FY25: ₹13,655 + ₹740 + ₹3,799 = ₹18,194 Cr on ₹1,42,290 Cr → 12.8%. 260 bps margin compression YoY.
Net profit margin: 5.3% in FY26 vs 8.8% in FY25 — a 350 bps erosion driven by gas marketing spread compression and petrochemical losses.
Other expenses surged 24.6% YoY (₹8,515 Cr → ₹10,613 Cr) — a cost-side deterioration that compounds the revenue-side weakness.

Growth Trajectory

Natural Gas Transmission (the high-quality, regulated annuity segment) grew EBIT 13.5% YoY (₹5,488 Cr → ₹6,229 Cr) — the one structural bright spot.
JV/associate profit contribution held flat at ~₹1,504 Cr — a stable but non-growing buffer.
EPS fell from ₹18.93 to ₹11.53 (-39.1%) with no equity dilution — the decline is purely earnings-driven, not structural.